290 related articles for article (PubMed ID: 26612622)
1. Exosomes from hypoxic endothelial cells have increased collagen crosslinking activity through up-regulation of lysyl oxidase-like 2.
de Jong OG; van Balkom BW; Gremmels H; Verhaar MC
J Cell Mol Med; 2016 Feb; 20(2):342-50. PubMed ID: 26612622
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane.
Bignon M; Pichol-Thievend C; Hardouin J; Malbouyres M; Bréchot N; Nasciutti L; Barret A; Teillon J; Guillon E; Etienne E; Caron M; Joubert-Caron R; Monnot C; Ruggiero F; Muller L; Germain S
Blood; 2011 Oct; 118(14):3979-89. PubMed ID: 21835952
[TBL] [Abstract][Full Text] [Related]
3. Scavenger Receptor Cysteine-Rich domains of Lysyl Oxidase-Like2 regulate endothelial ECM and angiogenesis through non-catalytic scaffolding mechanisms.
Umana-Diaz C; Pichol-Thievend C; Marchand MF; Atlas Y; Salza R; Malbouyres M; Barret A; Teillon J; Ardidie-Robouant C; Ruggiero F; Monnot C; Girard P; Guilluy C; Ricard-Blum S; Germain S; Muller L
Matrix Biol; 2020 Jun; 88():33-52. PubMed ID: 31759052
[TBL] [Abstract][Full Text] [Related]
4. Exogenous Lysyl Oxidase-Like 2 and Perfusion Culture Induce Collagen Crosslink Formation in Osteogenic Grafts.
Mitra D; Yasui OW; Harvestine JN; Link JM; Hu JC; Athanasiou KA; Leach JK
Biotechnol J; 2019 Mar; 14(3):e1700763. PubMed ID: 30052320
[TBL] [Abstract][Full Text] [Related]
5. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.
Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL
Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405
[TBL] [Abstract][Full Text] [Related]
6. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.
Iftikhar M; Hurtado P; Bais MV; Wigner N; Stephens DN; Gerstenfeld LC; Trackman PC
J Biol Chem; 2011 Jan; 286(2):909-18. PubMed ID: 21071451
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.
de Jong OG; van der Waals LM; Kools FRW; Verhaar MC; van Balkom BWM
J Cell Physiol; 2019 Jul; 234(7):10260-10269. PubMed ID: 30387148
[TBL] [Abstract][Full Text] [Related]
8. LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis.
Klepfish M; Gross T; Vugman M; Afratis NA; Havusha-Laufer S; Brazowski E; Solomonov I; Varol C; Sagi I
Front Immunol; 2020; 11():480. PubMed ID: 32296422
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV.
López-Jiménez AJ; Basak T; Vanacore RM
J Biol Chem; 2017 Oct; 292(41):16970-16982. PubMed ID: 28864775
[TBL] [Abstract][Full Text] [Related]
10. Human lysyl oxidase-like 2.
Moon HJ; Finney J; Ronnebaum T; Mure M
Bioorg Chem; 2014 Dec; 57():231-241. PubMed ID: 25146937
[TBL] [Abstract][Full Text] [Related]
11. LOXL2 in cancer: regulation, downstream effectors and novel roles.
Wen B; Xu LY; Li EM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188435. PubMed ID: 32976981
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.
Wong CC; Tse AP; Huang YP; Zhu YT; Chiu DK; Lai RK; Au SL; Kai AK; Lee JM; Wei LL; Tsang FH; Lo RC; Shi J; Zheng YP; Wong CM; Ng IO
Hepatology; 2014 Nov; 60(5):1645-58. PubMed ID: 25048396
[TBL] [Abstract][Full Text] [Related]
13. Lysyl Oxidase-like-2 Cross-links Collagen IV of Glomerular Basement Membrane.
Añazco C; López-Jiménez AJ; Rafi M; Vega-Montoto L; Zhang MZ; Hudson BG; Vanacore RM
J Biol Chem; 2016 Dec; 291(50):25999-26012. PubMed ID: 27770022
[TBL] [Abstract][Full Text] [Related]
14. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
15. Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.
Nguyen EV; Pereira BA; Lawrence MG; Ma X; Rebello RJ; Chan H; Niranjan B; Wu Y; Ellem S; Guan X; Wu J; Skhinas JN; Cox TR; Risbridger GP; Taylor RA; Lister NL; Daly RJ
Mol Cell Proteomics; 2019 Jul; 18(7):1410-1427. PubMed ID: 31061140
[TBL] [Abstract][Full Text] [Related]
16. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.
Schilter H; Findlay AD; Perryman L; Yow TT; Moses J; Zahoor A; Turner CI; Deodhar M; Foot JS; Zhou W; Greco A; Joshi A; Rayner B; Townsend S; Buson A; Jarolimek W
J Cell Mol Med; 2019 Mar; 23(3):1759-1770. PubMed ID: 30536539
[TBL] [Abstract][Full Text] [Related]
17. Lysyl oxidase like 2 is increased in asthma and contributes to asthmatic airway remodelling.
Ramis J; Middlewick R; Pappalardo F; Cairns JT; Stewart ID; John AE; Naveed SU; Krishnan R; Miller S; Shaw DE; Brightling CE; Buttery L; Rose F; Jenkins G; Johnson SR; Tatler AL
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34996828
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia preconditioned DPSC-derived exosomes regulate angiogenesis via transferring LOXL2.
Li B; Liang A; Zhou Y; Huang Y; Liao C; Zhang X; Gong Q
Exp Cell Res; 2023 Apr; 425(2):113543. PubMed ID: 36894050
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
Okada K; Moon HJ; Finney J; Meier A; Mure M
Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin.
Schmelzer CEH; Heinz A; Troilo H; Lockhart-Cairns MP; Jowitt TA; Marchand MF; Bidault L; Bignon M; Hedtke T; Barret A; McConnell JC; Sherratt MJ; Germain S; Hulmes DJS; Baldock C; Muller L
FASEB J; 2019 Apr; 33(4):5468-5481. PubMed ID: 30676771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
